Multiple roles of fibroblast growth factor 21 in metabolism

L I Li, Liling Tang1

  • 1College of Bioengineering, Chongqing University, Chongqing, 400044, China. tangliling@cqu.edu.cn.

Insights

Fibroblast growth factor 21 (FGF21) shows promise as a safe metabolic regulator for treating metabolic diseases. Research highlights its potential as a novel therapeutic agent for metabolic disorders.

Area of Science:

  • Endocrinology
  • Metabolic Research
  • Pharmacology

Background:

  • Metabolic diseases are increasing, necessitating safer and more effective treatments.
  • Fibroblast growth factor 21 (FGF21) is an endocrine hormone with beneficial metabolic effects and minimal adverse effects.
  • FGF21 plays a crucial role in regulating energy balance and substrate utilization.

Purpose of the Study:

  • To review the multifaceted roles of FGF21 in metabolic regulation.
  • To explore the therapeutic potential of FGF21 for metabolic disorders.
  • To discuss strategies for enhancing FGF21's therapeutic utility.

Main Methods:

  • Literature review of studies on FGF21.
  • Analysis of FGF21's function in response to high-fat diets.
  • Examination of the relationship between exercise and FGF21 expression.
  • Investigation of FGF21 interactions with key hormones.
  • Evaluation of FGF21 pharmacology and half-life extension methods.

Main Results:

  • FGF21 demonstrates significant influence on metabolism, particularly in high-fat diet contexts.
  • Exercise modulates FGF21 expression, suggesting a link between physical activity and FGF21's metabolic benefits.
  • FGF21 interacts with other hormones, indicating its integration into broader metabolic signaling networks.
  • Pharmacological approaches and half-life extension techniques show promise for therapeutic applications.

Conclusions:

  • FGF21 is a promising therapeutic candidate for metabolic disorders due to its safety and efficacy.
  • Understanding FGF21's functions provides a basis for developing novel drugs targeting metabolic diseases.
  • Further research into FGF21 pharmacology could lead to innovative treatments for metabolic dysfunction.

Related Concept Videos

Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
4.9K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
4.5K
Regulation of Metabolism01:19

Regulation of Metabolism

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
12.6K
Liver Physiology01:30

Liver Physiology

The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
4.5K
Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
37.9K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K